Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Clinical trial NCT02614846 · UNKNOWN
Trial details
- NCT number
- NCT02614846
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.